
Sign up to save your podcasts
Or


Using computers to create better drugs, faster, that are more efficient and with less side effects.
Our guest, Monica Berrondo, is the CEO and Co-Founder of Macromoltek.
Macromoltek is a Y Combinator from the Winter 2018 batch.
Learn more and connect with Monica:
Website: https://macromoltek.com/
Instagram: https://www.instagram.com/macromoltek/
LinkedIn: https://www.linkedin.com/in/monicaberrondo
Twitter: https://twitter.com/monicaberrondo
Listen to more Calls From the Future here: https://bit.ly/2STWsET
TIMESTAMPS:
0:03 Monica Berrondo Introduction
1:01 Antibodies as drugs
2:17 Monica's story
8:59 From PhD to realization
10:24 Antibody medicine development
16:06 The future technology
17:51 The story & future of biology
20:42 Catching up on Biology developments
23:07 Macromoltek timeline & future
27:53 Finding Investors
29:54 Scaling Macromoltek
32:29 Sales person for Macromoltek
37:10 Distribution of antibodies & FDA & The future
49:02 Why do you show up?
51:13 Follow up information
By CUsing computers to create better drugs, faster, that are more efficient and with less side effects.
Our guest, Monica Berrondo, is the CEO and Co-Founder of Macromoltek.
Macromoltek is a Y Combinator from the Winter 2018 batch.
Learn more and connect with Monica:
Website: https://macromoltek.com/
Instagram: https://www.instagram.com/macromoltek/
LinkedIn: https://www.linkedin.com/in/monicaberrondo
Twitter: https://twitter.com/monicaberrondo
Listen to more Calls From the Future here: https://bit.ly/2STWsET
TIMESTAMPS:
0:03 Monica Berrondo Introduction
1:01 Antibodies as drugs
2:17 Monica's story
8:59 From PhD to realization
10:24 Antibody medicine development
16:06 The future technology
17:51 The story & future of biology
20:42 Catching up on Biology developments
23:07 Macromoltek timeline & future
27:53 Finding Investors
29:54 Scaling Macromoltek
32:29 Sales person for Macromoltek
37:10 Distribution of antibodies & FDA & The future
49:02 Why do you show up?
51:13 Follow up information